DPP-4 Inhibitors for Type 2 Diabetes: Pharmacology Made Easy

In this lecture from This is Why, Dr. Busti will learn about the application of DPP-4 inhibitors in the management of type 2 diabetes mellitus (T2DM). The DPP-4 inhibitors (e.g., sitagliptin, linagliptin, saxagliptin) have an impact of incretins (GIP, GLP-1) which have continued to evolve in other treatment options.

You’ll learn how to:
- Mechanism of action: DPP-4 inhibition and impact on incretins (GLP-1/GIP) 
- Key drugs: Sitagliptin, linagliptin, saxagliptin
- Clinical role: where DPP-4 inhibitors fit in type 2 diabetes treatment, including add-on therapy
- Adverse effects & safety pearls: the side effects and warnings you need to know for exams and practice

The goal = make medical education easy and clinically relevant.

👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/dpp-4-inhibitors-sitagliptin-type-2-diabetes-pharmacology

👉 Get more with a free membership at https://www.thisiswhy.health/
- Access free downloads from our videos 
- Access deep dive content from Dr. Busti
- Organize content via playlists & collections
- Join live Q&A
- Receive member newsletters
- Coupons & discounts for exam prep resources

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#dpp4inhibitors #type2diabetes #sitagliptin #diabetespharmacology #busti

Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.